Upon the finalization of your order and payment, you explicitly acknowledge and agree to adhere to our Terms and Conditions
Blend ratio 5 : 1 (reta : cag) Retatrutide dominant 15 mg total per vial: 12.5 mg retatrutide and 2.5 mg cagrilintide
You may be a candidate if you: Are interested in evidence-informed longevity strategies Experience signs of aging such as stiffness, slower recovery, or fatigue Want physician-monitored care for investigational peptide therapy Seek safe, supervised access to cutting-edge anti-aging research Value personalized monitoring and adjustments as your body responds
When you are ready to start a new protocol, remove only the vials you need
Cycle-based research structure: Epithalon studies in the literature are often structured around defined experimental cycles rather than continuous exposure
DSIP works faster, with sleep pressure reported within hours, but even its full effects on sleep architecture normalization develop over multiple doses